Evaluation of Immunogenicity of Nivolumab Monotherapy and Its Clinical Relevance in Patients With Metastatic Solid Tumors.
about
Emerging treatment options for the management of Hodgkin's lymphoma: clinical utility of nivolumab.Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy.Model-Based Population Pharmacokinetic Analysis of Nivolumab in Patients With Solid Tumors.The role of nivolumab in melanoma.Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab.
P2860
Evaluation of Immunogenicity of Nivolumab Monotherapy and Its Clinical Relevance in Patients With Metastatic Solid Tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Evaluation of Immunogenicity o ...... With Metastatic Solid Tumors.
@en
Evaluation of Immunogenicity o ...... With Metastatic Solid Tumors.
@nl
type
label
Evaluation of Immunogenicity o ...... With Metastatic Solid Tumors.
@en
Evaluation of Immunogenicity o ...... With Metastatic Solid Tumors.
@nl
prefLabel
Evaluation of Immunogenicity o ...... With Metastatic Solid Tumors.
@en
Evaluation of Immunogenicity o ...... With Metastatic Solid Tumors.
@nl
P2093
P2860
P356
P1476
Evaluation of Immunogenicity o ...... With Metastatic Solid Tumors.
@en
P2093
Dharmesh D Desai
Gaurav Bajaj
Ian M Waxman
Jong-Soon Park
Manish Gupta
Paul Statkevich
Sally Saeger
Shruti Agrawal
P2860
P304
P356
10.1002/JCPH.818
P577
2016-08-25T00:00:00Z